Loading...
Bristol Myers Squibb (BMY): Undervalued Opportunity or Value Trap? A Deep Dive into 2024 Earnings and Fair Value
EV
Evangelos
Invested
Community Contributor
Published
24 Feb 25
Views
660
24 Feb
US$55.60
Evangelos's Fair Value
US$65.00
14.5% undervalued intrinsic discount1Y
10.8%7D
1.6%1Y
10.8%7D
1.6%You can edit this narrative until May 14 2:38 AM. Then, changes will post as Updates.
Author's Valuation
US$6514.5% undervalued intrinsic discount
Evangelos's Fair Value